Xenbucin sodium

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 341415

CAS#: 10265-80-2

Description: Xenbucin sodium is a biochemical.


Chemical Structure

img
Xenbucin sodium
CAS# 10265-80-2

Theoretical Analysis

MedKoo Cat#: 341415
Name: Xenbucin sodium
CAS#: 10265-80-2
Chemical Formula: C16H15NaO2
Exact Mass: 262.097
Molecular Weight: 262.2838
Elemental Analysis: C, 73.27; H, 5.76; Na, 8.77; O, 12.20

Price and Availability

This product is not in stock, which may be available by custom synthesis. For cost-effective reason, minimum order is 1g (price is usually high, lead time is 2~3 months, depending on the technical challenge). Quote less than 1g will not be provided. To request quote, please email to sales @medkoo.com or click below button.
Note: Price will be listed if it is available in the future.

Request quote for custom synthesis

Synonym: Xenbucin sodium; Lyosol.

IUPAC/Chemical Name: (1,1'-Biphenyl)-4-acetic acid, alpha-ethyl-, sodium salt (1:1)

InChi Key: OLGONLPBKFPQNS-UHFFFAOYSA-M

InChi Code: InChI=1S/C16H16O2.Na/c1-2-15(16(17)18)14-10-8-13(9-11-14)12-6-4-3-5-7-12;/h3-11,15H,2H2,1H3,(H,17,18);/q;+1/p-1

SMILES Code: O=C([O-])C(CC)C1=CC=C(C2=CC=CC=C2)C=C1.[Na+]

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO

Shelf Life: >2 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.9001

Preparing Stock Solutions

The following data is based on the product molecular weight 262.2838 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

1: Preston TM, Borgreen MJ, Ray AM. Effects of brine contamination from energy development on wetland macroinvertebrate community structure in the Prairie Pothole Region. Environ Pollut. 2018 Apr 30;239:722-732. doi: 10.1016/j.envpol.2018.04.088. [Epub ahead of print] PubMed PMID: 29723822.

2: Augustine R, Ashkenazi DL, Arzi RS, Zlobin V, Shofti R, Sosnik A. Nanoparticle-in-Microparticle Oral Drug Delivery System of a Clinically Relevant Darunavir/Ritonavir Antiretroviral Combination. Acta Biomater. 2018 Apr 30. pii: S1742-7061(18)30248-4. doi: 10.1016/j.actbio.2018.04.045. [Epub ahead of print] PubMed PMID: 29723705.

3: Huong KH, Elina KAR, Amirul AA. Production of high molecular weight poly(3-hydroxybutyrate-co-4-hydroxybutyrate) copolymer by Cupriavidus malaysiensis USMAA1020 utilising substrate with longer carbon chain. Int J Biol Macromol. 2018 Apr 30. pii: S0141-8130(18)31192-9. doi: 10.1016/j.ijbiomac.2018.04.148. [Epub ahead of print] PubMed PMID: 29723627.

4: Fallacara A, Busato L, Pozzoli M, Ghadiri M, Ong HX, Young PM, Manfredini S, Traini D. Combination of urea-crosslinked hyaluronic acid and sodium ascorbyl phosphate for the treatment of inflammatory lung diseases: An in vitro study. Eur J Pharm Sci. 2018 Apr 30. pii: S0928-0987(18)30207-0. doi: 10.1016/j.ejps.2018.04.042. [Epub ahead of print] PubMed PMID: 29723596.

5: Srivastava P, Dhuriya YK, Kumar V, Srivastava A, Gupta R, Shukla RK, Yadav RS, Dwivedi HN, Pant AB, Khanna VK. PI3K/Akt/GSK3β induced CREB activation ameliorates arsenic mediated alterations in NMDA receptors and associated signaling in rat hippocampus: Neuroprotective role of curcumin. Neurotoxicology. 2018 Apr 30. pii: S0161-813X(18)30161-X. doi: 10.1016/j.neuro.2018.04.018. [Epub ahead of print] PubMed PMID: 29723552.

6: Nio Y, Akahori Y, Okamura H, Watashi K, Wakita T, Hijikata M. Inhibitory effect of fasiglifam on hepatitis B virus infections through suppression of the sodium taurocholate cotransporting polypeptide. Biochem Biophys Res Commun. 2018 Apr 30. pii: S0006-291X(18)30996-3. doi: 10.1016/j.bbrc.2018.04.199. [Epub ahead of print] PubMed PMID: 29723527.

7: Assumpção D, Senicato C, Fisberg RM, Canesqui AM, Barros MBA. Are there differences in the quality of the diet of working and stay-at-home women? Rev Saude Publica. 2018;52:47. doi: 10.11606/s1518-8787.2018052000104. Epub 2018 May 3. Portuguese, English. PubMed PMID: 29723387.

8: Gong Y, Yang J, Wu W, Liu F, Su A, Li Z, Zhu J, Wei T. Preserved SCN4B expression is an independent indicator of favorable recurrence-free survival in classical papillary thyroid cancer. PLoS One. 2018 May 3;13(5):e0197007. doi: 10.1371/journal.pone.0197007. eCollection 2018. PubMed PMID: 29723302.

9: Moyer BD, Murray JK, Ligutti J, Andrews K, Favreau P, Jordan JB, Lee JH, Liu D, Long J, Sham K, Shi L, Stöcklin R, Wu B, Yin R, Yu V, Zou A, Biswas K, Miranda LP. Pharmacological characterization of potent and selective NaV1.7 inhibitors engineered from Chilobrachys jingzhao tarantula venom peptide JzTx-V. PLoS One. 2018 May 3;13(5):e0196791. doi: 10.1371/journal.pone.0196791. eCollection 2018. PubMed PMID: 29723257.

10: Qu X, Yin C, Sun X, Huang S, Li C, Dong P, Lu X, Zhang Z, Yin A. Consumption of antibiotics in Chinese public general tertiary hospitals (2011-2014): Trends, pattern changes and regional differences. PLoS One. 2018 May 3;13(5):e0196668. doi: 10.1371/journal.pone.0196668. eCollection 2018. PubMed PMID: 29723230.

11: Peters GJ. Antipyrimidine effects of five different pyrimidine de novo synthesis inhibitors in three head and neck cancer cell lines. Nucleosides Nucleotides Nucleic Acids. 2018 May 3:1-11. doi: 10.1080/15257770.2018.1460479. [Epub ahead of print] PubMed PMID: 29723133.

12: Chiu YH, Chen MC, Wan SW. Sodium Hyaluronate/Chitosan Composite Microneedles as a Single-Dose Intradermal Immunization System. Biomacromolecules. 2018 May 3. doi: 10.1021/acs.biomac.8b00441. [Epub ahead of print] PubMed PMID: 29722966.

13: Doubova SV, Josefa-García H, Coronado-Zarco IA, Carrera-Muiños S, Cordero-Gonzalez G, Cruz-Reynoso L, Mateos-Sanchez L, Maya-García AJ, Pérez-Cuevas R. Evaluating the quality of the processes of care and clinical outcomes of premature newborns admitted to neonatal intensive care units in Mexico. Int J Qual Health Care. 2018 Apr 4. doi: 10.1093/intqhc/mzy061. [Epub ahead of print] PubMed PMID: 29722867.

14: Zwart SR, Rice BL, Dlouhy H, Shackelford LC, Heer M, Koslovsky MD, Smith SM. Dietary acid load and bone turnover during long-duration spaceflight and bed rest. Am J Clin Nutr. 2018 May 1;107(5):834-844. doi: 10.1093/ajcn/nqy029. PubMed PMID: 29722847.

15: Enerbäck H, Möller M, Nylén C, Ödman Bresin C, Östman Ros I, Westerlund A. Effects of orthodontic treatment and different fluoride regimens on numbers of cariogenic bacteria and caries risk: a randomized controlled trial. Eur J Orthod. 2018 May 2. doi: 10.1093/ejo/cjy025. [Epub ahead of print] PubMed PMID: 29722800.

16: Hassan F, Murrell WD, Refalo A, Maffulli N. Alternatives to Biologics in Management of Knee Osteoarthritis: A Systematic Review. Sports Med Arthrosc Rev. 2018 Jun;26(2):79-85. doi: 10.1097/JSA.0000000000000190. PubMed PMID: 29722769.

17: Terwoord JD, Hearon CM Jr., Luckasen GJ, Richards JC, Joyner MJ, Dinenno FA. Elevated extracellular potassium prior to muscle contraction reduces onset and steady-state exercise hyperemia in humans. J Appl Physiol (1985). 2018 May 3. doi: 10.1152/japplphysiol.00183.2018. [Epub ahead of print] PubMed PMID: 29722620.

18: de Oliveira LF, Saunders B, Artioli GG. Is By-passing the Stomach a Means to Optimise Sodium Bicarbonate Supplementation? A Case-study With a Post-Bariatric Surgery Individual. Int J Sport Nutr Exerc Metab. 2018 May 3:1-15. doi: 10.1123/ijsnem.2017-0394. [Epub ahead of print] PubMed PMID: 29722576.

19: Wu J, Zeng RJ. In situ preparation of stabilized iron sulfide nanoparticles-impregnated alginate composite for selenite remediation. Environ Sci Technol. 2018 May 3. doi: 10.1021/acs.est.7b05861. [Epub ahead of print] PubMed PMID: 29722535.

20: Čulić V. Angiography with Sodium Bicarbonate and Acetylcysteine. N Engl J Med. 2018 May 3;378(18):1749. doi: 10.1056/NEJMc1803605. PubMed PMID: 29722513.